
Precision BioSciences (NASDAQ:DTIL) brought in sales totaling $6.34 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 97.62%, resulting in a loss of $22.29 million. Precision BioSciences collected $24.04 million in revenue during Q3, but reported earnings showed a $11.28 million loss.